Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury

Mario Menk, Jan Adriaan Graw, Clarissa von Haefen, Hendrik Steinkraus, Burkhard Lachmann, Claudia D Spies, David Schwaiberger Department of Anesthesiology and Operative Intensive Care Medicine, Charité – University Medicine Berlin, FreieUniversität Berlin, Humboldt-Univ...

Full description

Bibliographic Details
Main Authors: Menk M, Graw JA, von Haefen C, Steinkraus H, Lachmann B, Spies CD, Schwaiberger D
Format: Article
Language:English
Published: Dove Medical Press 2018-05-01
Series:Journal of Inflammation Research
Subjects:
Online Access:https://www.dovepress.com/angiotensin-ii-type-2-receptor-agonist-compound-21-attenuates-pulmonar-peer-reviewed-article-JIR
id doaj-0c0452c5e4494ddca7fab04d21ccd0f3
record_format Article
spelling doaj-0c0452c5e4494ddca7fab04d21ccd0f32020-11-25T00:09:56ZengDove Medical PressJournal of Inflammation Research1178-70312018-05-01Volume 1116917838078Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injuryMenk MGraw JAvon Haefen CSteinkraus HLachmann BSpies CDSchwaiberger DMario Menk, Jan Adriaan Graw, Clarissa von Haefen, Hendrik Steinkraus, Burkhard Lachmann, Claudia D Spies, David Schwaiberger Department of Anesthesiology and Operative Intensive Care Medicine, Charité – University Medicine Berlin, FreieUniversität Berlin, Humboldt-Universitätzu Berlin, and Berlin Institute of Health, Germany Purpose: Although the role of the angiotensin II type 2 (AT2) receptor in acute lung injury is not yet completely understood, a protective role of this receptor subtype has been suggested. We hypothesized that, in a rodent model of acute lung injury, stimulation of the AT2 receptor with the direct agonist Compound 21 (C21) might have a beneficial effect on pulmonary inflammation and might improve pulmonary gas exchange. Materials and methods: Male adult rats were divided into a treatment group that received pulmonary lavage followed by mechanical ventilation (LAV, n=9), a group receiving pulmonary lavage, mechanical ventilation, and direct stimulation of the AT2 receptor with C21 (LAV+C21, n=9), and a control group that received mechanical ventilation only (control, n=9). Arterial blood gas analysis was performed every 30 min throughout the 240-min observation period. Lung tissue and plasma samples were obtained at 240 min after the start of mechanical ventilation. Protein content and surface activity of bronchoalveolar lavage fluid were assessed and the wet/dry-weight ratio of lungs was determined. Transcriptional and translational regulation of pro- and antiinflammatory cytokines IL-1β, tumor necrosis factor-alpha, IL-6, IL-10, and IL-4 was determined in lungs and in plasma. Results: Pulmonary lavage led to a significant impairment of gas exchange, the formation of lung edema, and the induction of pulmonary inflammation. Protein content of lavage fluid was increased and contained washed-out surfactant. Direct AT2 receptor stimulation with C21 led to a significant inhibition of tumor necrosis factor-alpha and IL-6 expressions in the lungs, whereas the expressions of IL-1, IL-10, and IL-4 remained unchanged. During the 240-min observation period, AT2 receptor stimulation did not improve pulmonary gas exchange or lung edema. Conclusion: In this rodent model of acute lung injury after repeated pulmonary lavage, AT2 receptor stimulation attenuates pulmonary inflammation but does not improve gas exchange. Keywords: AT2 receptor, lung failure, ARDS, acute lung injury, Compound 21 (C21)https://www.dovepress.com/angiotensin-ii-type-2-receptor-agonist-compound-21-attenuates-pulmonar-peer-reviewed-article-JIRAT2 receptorlung failureARDSacute lung injuryCompound 21 (C21)
collection DOAJ
language English
format Article
sources DOAJ
author Menk M
Graw JA
von Haefen C
Steinkraus H
Lachmann B
Spies CD
Schwaiberger D
spellingShingle Menk M
Graw JA
von Haefen C
Steinkraus H
Lachmann B
Spies CD
Schwaiberger D
Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury
Journal of Inflammation Research
AT2 receptor
lung failure
ARDS
acute lung injury
Compound 21 (C21)
author_facet Menk M
Graw JA
von Haefen C
Steinkraus H
Lachmann B
Spies CD
Schwaiberger D
author_sort Menk M
title Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury
title_short Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury
title_full Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury
title_fullStr Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury
title_full_unstemmed Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury
title_sort angiotensin ii type 2 receptor agonist compound 21 attenuates pulmonary inflammation in a model of acute lung injury
publisher Dove Medical Press
series Journal of Inflammation Research
issn 1178-7031
publishDate 2018-05-01
description Mario Menk, Jan Adriaan Graw, Clarissa von Haefen, Hendrik Steinkraus, Burkhard Lachmann, Claudia D Spies, David Schwaiberger Department of Anesthesiology and Operative Intensive Care Medicine, Charité – University Medicine Berlin, FreieUniversität Berlin, Humboldt-Universitätzu Berlin, and Berlin Institute of Health, Germany Purpose: Although the role of the angiotensin II type 2 (AT2) receptor in acute lung injury is not yet completely understood, a protective role of this receptor subtype has been suggested. We hypothesized that, in a rodent model of acute lung injury, stimulation of the AT2 receptor with the direct agonist Compound 21 (C21) might have a beneficial effect on pulmonary inflammation and might improve pulmonary gas exchange. Materials and methods: Male adult rats were divided into a treatment group that received pulmonary lavage followed by mechanical ventilation (LAV, n=9), a group receiving pulmonary lavage, mechanical ventilation, and direct stimulation of the AT2 receptor with C21 (LAV+C21, n=9), and a control group that received mechanical ventilation only (control, n=9). Arterial blood gas analysis was performed every 30 min throughout the 240-min observation period. Lung tissue and plasma samples were obtained at 240 min after the start of mechanical ventilation. Protein content and surface activity of bronchoalveolar lavage fluid were assessed and the wet/dry-weight ratio of lungs was determined. Transcriptional and translational regulation of pro- and antiinflammatory cytokines IL-1β, tumor necrosis factor-alpha, IL-6, IL-10, and IL-4 was determined in lungs and in plasma. Results: Pulmonary lavage led to a significant impairment of gas exchange, the formation of lung edema, and the induction of pulmonary inflammation. Protein content of lavage fluid was increased and contained washed-out surfactant. Direct AT2 receptor stimulation with C21 led to a significant inhibition of tumor necrosis factor-alpha and IL-6 expressions in the lungs, whereas the expressions of IL-1, IL-10, and IL-4 remained unchanged. During the 240-min observation period, AT2 receptor stimulation did not improve pulmonary gas exchange or lung edema. Conclusion: In this rodent model of acute lung injury after repeated pulmonary lavage, AT2 receptor stimulation attenuates pulmonary inflammation but does not improve gas exchange. Keywords: AT2 receptor, lung failure, ARDS, acute lung injury, Compound 21 (C21)
topic AT2 receptor
lung failure
ARDS
acute lung injury
Compound 21 (C21)
url https://www.dovepress.com/angiotensin-ii-type-2-receptor-agonist-compound-21-attenuates-pulmonar-peer-reviewed-article-JIR
work_keys_str_mv AT menkm angiotensiniitype2receptoragonistcompound21attenuatespulmonaryinflammationinamodelofacutelunginjury
AT grawja angiotensiniitype2receptoragonistcompound21attenuatespulmonaryinflammationinamodelofacutelunginjury
AT vonhaefenc angiotensiniitype2receptoragonistcompound21attenuatespulmonaryinflammationinamodelofacutelunginjury
AT steinkraush angiotensiniitype2receptoragonistcompound21attenuatespulmonaryinflammationinamodelofacutelunginjury
AT lachmannb angiotensiniitype2receptoragonistcompound21attenuatespulmonaryinflammationinamodelofacutelunginjury
AT spiescd angiotensiniitype2receptoragonistcompound21attenuatespulmonaryinflammationinamodelofacutelunginjury
AT schwaibergerd angiotensiniitype2receptoragonistcompound21attenuatespulmonaryinflammationinamodelofacutelunginjury
_version_ 1725409919112314880